We're sorry but the Program doesn't work properly without JavaScript enabled. Please enable it to continue.
Horizontal
Vertical
List
Program
Chairs & Speakers
Favourites
Download Program
Help
Event Times (GMT+1)
Local Times (GMT+2)
Login
Session Groups
Session Types
Networking
Data Blitz Session
Spotlight Session
Symposium
Meet the Experts / Campfire Session
Plenary
Break
Session
Industry
Posters
Featured Communication
Rooms
Back
Posters
Poster Area
Saturday, June 27, 10:15 AM – 10:45 AM
Poster Session 1: Depression
Chair:
Laura Musazzi (Monza, Italy)
A single high-dose acute injection of 5-MeO-DMT reverses stress-induced anhedonia in rats
Speaker:
Sasha Socolow (Montreal, Canada)
Genome-wide DNA methylation analysis reveals epigenetic signatures of early life stress in major depressive disorder patients
Speaker:
Yogesh Dwivedi (Birmingham, United States)
Association of depression and antidepressant treatment with pregnancy outcomes in infertility care
Speaker:
Joo Eon Park (Uiwang-si, Korea, Republic of)
Acute modulation of cortical excitability by high-dose intermittent theta burst stimulation: a TMS-EEG study
Speaker:
Sharie Xiao Wang (Hong Kong, China)
Adaptive immune system changes related to stress and depression: clinical and preclinical insights
Speaker:
Stacey Kigar (Cambridge, United Kingdom)
Genetic and neuroimaging correlates of symptom severity in major depressive disorder: an imaging–genetics study
Speaker:
Seung-Gul Kang (Incheon, Korea, Republic of)
Possible anti-inflammatory effects of escitalopram (SSRI): reverse-translational study using human blood induced microglia-like (iMG) cells
Speaker:
Keito Hiyoshi (Fukuoka, Japan)
Blood–brain barrier permeability of antihistamines and risk of depression in children and adolescents: a real-world cohort study
Speaker:
Chia Chien Liu (Taichung, Taiwan)
Angular gyrus as a key hub of treatment refractoriness and neuromodulation response in major depressive disorder: a data-driven structural covariance network analysis
Speaker:
Cheng-Ta Li (Taipei, Taiwan)
Suicidal symptoms as central nodes in late-life depression: a network analysis in older Koreans
Speaker:
Sungman Chang (Daegu, Korea, Republic of)
Polygenic stratification reveals differential response to V1b antagonism in pre-exposed patients with major depressive disorder: a post-hoc analysis of the phase 2 OLIVE trial
Speaker:
Daniel Gehrlach (Munich, Germany)
Vagus nerve stimulation reduces suicidal ideation in markedly treatment-resistant depression: RECOVER findings
Speaker:
A. John Rush (Singapore, Singapore)
Primary neuronal cultures to study neuroplastic effects of hallucinogen drugs
Speaker:
Noemi Nicosia (Monza, Italy)
Effect of home-based self-administered transcranial direct stimulation in patients with depressive disorder
Speaker:
Jeong-Ho Chae (Seoul, Korea, Republic of)
Restoration by ketamine metabolites of cognitive and affective prosocial behaviors in a mouse model of depression
Speaker:
Rei Yokoyama (Hiroshima, Japan)
The effect of childhood trauma on drug resistance in major depressive disorder - results from the international PROMPT study
Speaker:
Ewa Ferensztajn-Rochowiak (Poznań, Poland)
Antidepressant prescribing patterns at initial visits for patients with mild depression: a retrospective study
Speaker:
Minoru Urata (Tokyo, Japan)
Task-based fMRI investigation of neural changes following acceptance and commitment therapy in major depressive disorder
Speaker:
Seung Jae Lee (Daegu, Korea, Republic of)
Alterations of the event-related potential parameter P300 in antidepressant vagus nerve stimulation: preliminary results of a longitudinal prospective study
Speaker:
Natalia Grüll (Vienna, Austria)
Increased preference transitivity as a marker of cognitive rigidity in major depressive disorder
Speaker:
Yong Wook Shin (Seoul, Korea, Republic of)
Chronic stress induces behavioral changes through increased kynurenic acid by downregulation of kynurenine-3-monooxygenase with microglial decline
Speaker:
Masaya Hasegawa (Aichi, Japan)
Relationship between childhood adversity and pre-operative structural MRI data in patients receiving deep brain stimulation of the subgenual cingulate cortex for treatment resistant depression
Speaker:
Enoch Ng (Toronto, Canada)
Blood-brain barrier permeability as a determinant of depression risk in long-term beta-blocker users: a real-world TriNetX cohort study
Speaker:
Chen-Chia Lan (Taichung, Taiwan)
Influence of individual personality on health functioning among medical students: a comparative study between Japan and Brazil
Speaker:
Haruki Fujitsuka (Hamamatsu, Japan)
Efficacy of adjunctive lumateperone 42 mg treatment across patient-reported depression symptoms in major depressive disorder
Speaker:
Willie R. Earley (Bedminster, United States)
Mass spectrometry imaging uncovers species-specific dopaminergic effects of tetrabenazine in rodents
Speaker:
Sarah Diez (Biberach, Germany)
Early improvement predicts subsequent antidepressant response to intravenous ketamine
Speaker:
Omer Syed (Toronto, Canada)
Atypical depression detection using speech based on the CAM++ artificial intelligence model
Speaker:
Lan Wang (Shijiazhuang, China)
A head-to-head comparison of two biologically-based subtyping solutions for major depressive disorder
Speaker:
Katharine Dunlop (Toronto, Canada)
A case of prolonged delirium after the application of electroconvulsive therapy in the treatment of recurrent depressive disorder
Speaker:
Marija Drašković Edisvog (Kragujevac, Serbia)
Subjective health perception moderates the antidepressant effects of home-based transcranial direct current stimulation in perinatal women: a real-world observational study
Speaker:
Min-Kyoung Kim (Goyang, Korea, Republic of)
Early irritability change in males predicts antidepressant response to DLPFC-rTMS
Speaker:
Sarah Smith (Toronto, Canada)
Impact of adverse childhood experiences on brain stimulation outcomes for depression
Speaker:
Enoch Ng (Toronto, Canada)
Plasma neurofilament light chain levels in drug-free patients with major depressive disorder and changes after antidepressant treatment: a longitudinal pilot study
Speaker:
Chun-Hsin Chen (Taipei, Taiwan)
Association between subjective experiences and symptom improvement following psilocybin therapy in Japanese patients with treatment-resistant depression: an open-label study
Speaker:
Lisa Harada (Tokyo, Japan)
Psilocybin reveals diverse antidepressant efficacies across different preclinical models of depression
Speaker:
Gianluca russo (NA, China)
Psilocin pharmacokinetics and exposure-response relationships in Japanese patients with treatment-resistant depression receiving psilocybin therapy: an open-label study
Speaker:
Keisuke Kusudo (Shinjuku-ku, Tokyo, Japan)
Multidomain behavioural profiling in the Flinders Sensitive Line rat and response to escitalopram or a novel butyrylcholinesterase inhibitor: focus on anhedonia
Speaker:
Nadia Olivier (Potchefstroom, South Africa)
Biomarkers of ketamine efficacy: role of the kynurenine pathway
Speaker:
Bruno Pedraz Petrozzi (Mannheim, Germany)
Prophylactic effects of LSD on inflammatory rodent model of depression
Speaker:
Amel Bouloufa (Bron, France)
Korean longitudinal study on digitally optimized mental healthcare: a cohort profile
Speaker:
Jonghun Lee (Daegu, Korea, Republic of)
Intensive longitudinal monitoring of symptoms in response to treatment with intranasal esketamine
Speaker:
Marko Saje (Ljubljana, Slovenia)
Predicting psychiatric symptom deterioration using heart rate variability: the role of temporal feature engineering
Speaker:
Min Kyung Kim (Seoul, Korea, Republic of)
Effects of psilocybin treatment on cognitive function in Japanese patients with treatment-resistant depression: an open-label study
Speaker:
Sota Tomiyama (Tokyo, Japan)
Feasibility of psilocybin treatment in Japanese patients with treatment-resistant depression: an open-label study
Speaker:
Kengo Yonezawa (Tokyo, Japan)
One-month ronadside ambient PM
2.5
does ot worsen lung or hippocampal inflammation in an LPS-induced COPD mouse model
Speaker:
Zonghao Ma (Hong Kong, Hong Kong)
Desvenlafaxine in the treatment of major depressive disorder
Speaker:
Christos Istikoglou (Athens, Greece)
Cerebrospinal fluid p75 neurotrophin receptor ectodomain differs between Alzheimer’s disease and late-life depression: links to cognition, sleep, and anxiety
Speaker:
Wataru Omori (Kure, Japan)
Impact of having or living with a family member with dementia on suicidal ideation: mediating effect of sleep duration, quality of life, and depressive symptoms
Speaker:
Dham Ho (Seoul, Korea, Republic of)
Toward a brief, sensitive tool to assess depressive symptom outcomes in research and clinical practice: lessons from the RECOVER trial
Speaker:
A. John Rush (Singapore, Singapore)
Integrating structured hospital-based psychosocial case management into national suicide prevention in South Korea: a multicentre, assessor-blinded, randomised controlled trial
Speaker:
Jong Woo Paik (Seoul, Korea, Republic of)
ECT-induced effects on brain structure, brain connectivity and cerebrospinal-fluid-based markers – a preliminary analysis
Speaker:
Pia Baldinger-Melich (Vienna, Austria)
Female-specific role of interleukin 6 and C-reactive protein in individuals with major depressive disorder and comorbid obesity
Speaker:
Giulia Lombardo (London, United Kingdom)
Study of behavioural, molecular, morphological and electrophysiological effects of chronic stress in mice
Speaker:
Mattia Giovenzana (Monza, Italy)